Pfizer
Aamir Malik is Executive Vice President, Chief U.S. Commercial Officer, Pfizer Inc. Aamir is a member of Pfizer’s Executive Leadership Team (ELT). He leads the U.S. Commercial business, which consists of U.S. Primary and Specialty Care, as well as Global Value and Access, Global Medical Affairs, and Global Chief Marketing Office organizations.
Previously Aamir served as the Executive Vice President, Chief Business Innovation Officer, responsible for the company’s strategy, business development, commercial development, portfolio management, pipeline prioritization, and formation of new business ventures.
Prior to joining Pfizer, Aamir was the Managing Partner of McKinsey & Company’s United States operations and previously led the firm’s Global Pharmaceutical and Medical Products Practice. In his 25 years at McKinsey, Aamir developed innovative growth strategies, guided mergers and acquisitions, and implemented high-impact programs to improve patients’ lives and transform performance for life science companies. He has advised many Boards, CEOs, and top management teams in the life science space.
Aamir earned a Bachelor of Science in finance from Indiana University and currently serves on the University’s Kelly School of Business Dean’s Council. He is an active advocate for bettering the lives of people with food allergies and has lived and worked globally, including in the United States, Europe, Asia, Latin America, and Africa.
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.